[System valid from October 1, 2023 until March 31, 2024]
Public expense subsidy (when hospitalized for treatment for the new coronavirus)
The following items (1) and (2) are covered by public funds.
(1) Part of the medical costs of hospitalization due to coronavirus infection.
(2) Part of drug costs when the following high-cost drugs are prescribed for treatment.
- Oral medicines “Lagebrio”, “Paxlovid” and “Xocova”.
- Intravenous medications ” Vecluri “.
- Neutralizing antibody medications “Zebudi”, “Lonaprieve” and “Evusheld”.
Details of the subsidy to cover part of the costs of medicines
In principle, public funds subsidize so that the maximum amount to be paid by the patient is the treatment costs minus 10,000 yen in the high-cost healthcare system.
* Click here for the maximum payment amount after reduction by public funds.
Click here for information about the subsidy when receiving outpatient treatment for coronavirus treatment.
